485 research outputs found
Trends in incidence and mortality of tuberculosis in Japan : a population-based study, 1997–2016
Japan is still a medium-burden tuberculosis (TB) country. We aimed to examine trends in newly notified active TB incidence and TB-related mortality in the last two decades in Japan. This is a population-based study using Japanese Vital Statistics and Japan Tuberculosis Surveillance from 1997 to 2016. We determined active TB incidence and mortality rates (per 100 000 population) by sex, age and disease categories. Joinpoint regression was applied to calculate the annual percentage change (APC) in age-adjusted mortality rates and to identify the years showing significant trend changes. Crude and age-adjusted incidence rates reduced from 33.9 to 13.9 and 37.3 to 11.3 per 100 000 population, respectively. Also, crude and age-adjusted mortality rates reduced from 2.2 to 1.5 and 2.8 to 1.0 per 100 000 population, respectively. Average APC in the incidence and mortality rates showed significant decline both in men (−6.2% and −5.4%, respectively) and women (−5.7% and −4.6%, respectively). Age-specific analysis demonstrated decreases in incidence and mortality rates for every age category, except for the incidence trend in the younger population. Although trends in active TB incidence and mortality rates in Japan have favourably decreased, the rate of decline is far from achieving TB elimination by 2035
AN APPROACH FOR THE OPTIMUM HYDRODYNAMIC DESIGN OF HYDROKINETIC TURBINE BLADES
This work aims to develop a simple and efficient mathematical model applied to optimization of horizontal-axis hydrokinetic turbine blades considering the cavitation effect. The approach uses the pressure minimum coefficient as a criterion for the cavitation limit on the flow around the hydrokinetic blades. The methodology corrects the chord and twist angle at each blade section by a modification on the local thrust coefficient in order to takes into account the cavitation on the rotor shape. The optimization is based on the Blade Element Theory (BET), which is a well known method applied to design and performance analysis of wind and hydrokinetic turbines, which usually present good agreement with experimental data. The results are compared with data obtained from hydrokinetic turbines designed by the classical Glauert's optimization. The present method yields good behavior, and can be used as an alternative tool in efficient hydrokinetic turbine designs
Fluorescence multispectral imaging-based diagnostic system for atherosclerosis
Background: Composition of atherosclerotic arterial walls is rich in lipids such as cholesterol, unlike normal arterial walls. In this study, we aimed to utilize this difference to diagnose atherosclerosis via multispectral fluorescence imaging, which allows for identification of fluorescence originating from the substance in the arterial wall. Methods: The inner surface of extracted arteries (rabbit abdominal aorta, human coronary artery) was illuminated by 405 nm excitation light and multispectral fluorescence images were obtained. Pathological examination of human coronary artery samples were carried out and thickness of arteries were calculated by measuring combined media and intima thickness. Results: The fluorescence spectra in atherosclerotic sites were different from those in normal sites. Multiple regions of interest (ROI) were selected within each sample and a ratio between two fluorescence intensity differences (where each intensity difference is calculated between an identifier wavelength and a base wavelength) from each ROI was determined, allowing for discrimination of atherosclerotic sites. Fluorescence intensity and thickness of artery were found to be significantly correlated. Conclusions: These results indicate that multispectral fluorescence imaging provides qualitative and quantitative evaluations of atherosclerosis and is therefore a viable method of diagnosing the disease
Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis
Summary: The MOVEST study evaluated the efficacy and safety of monthly oral ibandronate versus licensed monthly IV ibandronate in Japanese osteoporotic patients. Relative BMD gains after 12 months were 5.22 % oral and 5.34 % IV, showing non-inferiority of oral to IV ibandronate (primary endpoint). No new safety concerns were identified. Introduction: The randomized, phase 3, double-blind MOVEST (Monthly Oral VErsus intravenouS ibandronaTe) study evaluated the efficacy and safety of monthly oral ibandronate versus the licensed monthly intravenous (IV) ibandronate regimen in Japanese patients with osteoporosis. Methods: Ambulatory patients aged ?55 years with primary osteoporosis were randomized to receive oral ibandronate 100 mg/month plus monthly IV placebo, or IV ibandronate 1 mg/month plus monthly oral placebo. The primary endpoint was non-inferiority of oral versus IV ibandronate with respect to bone mineral density (BMD) gains at the lumbar spine after 12 months of treatment. Results: Four hundred twenty-two patients were enrolled with 372 patients in the per-protocol set (183 and 189 in the oral and IV ibandronate groups, respectively). The relative change from baseline in lumbar spine BMD values for the oral and IV ibandronate groups, respectively, was 5.22 % (95 % confidence interval [CI] 4.65, 5.80) and 5.34 % (95 % CI 4.78, 5.90). The least squares mean difference between the two groups was ?0.23 % (95 % CI ?0.97, 0.51), showing non-inferiority of oral ibandronate to IV ibandronate (non-inferiority limit = ?1.60). Changes in BMD values at other sites, and bone turnover marker levels in the oral ibandronate group, were comparable with those of the IV group. The safety profile was similar to that previously demonstrated; no new safety concerns were identified. Conclusions: This study demonstrated the non-inferiority of oral ibandronate 100 mg/month to IV ibandronate 1 mg/month (licensed dose in Japan) in increasing lumbar spine BMD in Japanese patients with primary osteoporosis
A study of passive weight-bearing lower limb exercise effects on local muscles and whole body oxidative metabolism: a comparison with simulated horse riding, bicycle, and walking exercise
Improved measurement of time-dependent CP violation in B0 -> J/Psi pi0 decays
We report improved measurements of time-dependent CP violation parameters for
decay. This analysis is based on 535 million
pairs accumulated at the resonance with the Belle
detector at the KEKB asymmetric-energy e^+e^- collider. From the distribution
of proper time intervals between the two B decays, we obtain the following CP
violation parameters and , which are consistent with Standard Model
expectations.Comment: Resubmitted to PRD(RC), including 4 figures, 6pages Revision has been
made according to communication with PRD referee
Observation of B^0 \to D^{*-} \tau^+ \nu_{\tau} decay at Belle
We report an observation of the decay in a
data sample containing pairs collected with the
Belle detector at the KEKB asymmetric-energy collider. We find a
signal with a significance of 5.2 standard deviations and measure the branching
fraction . This is the first observation of an exclusive
decay with a transition.Comment: 6 pages, 3 figures, submitted to Phys. Rev. Let
Search for B -> h(*) nu nubar Decays at Belle
We present a search for the rare decays B -> h(*) nu nubar, where h(*) stands
for a light meson. A data sample of 535 million BBbar pairs collected with the
Belle detector at the KEKB e+e- collider is used. Signal candidates are
required to have an accompanying B meson fully reconstructed in a hadronic mode
and signal-side particles consistent with a single h(*) meson. No significant
signal is observed and we set upper limits on the branching fractions at 90%
confidence level. The limits on B0 -> K*0 nu nubar and B+ -> K+ nu nubar decays
are more stringent than the previous constraints, while the first searches for
B0 -> K0 nu nubar, pi0 nu nubar, rho0 nu nubar, phi nu nubar and B+ -> K*+ nu
nubar, rho+ nu nubar are reported.Comment: 6 pages, 2 figures, submit to PR
- …